Work

Effect of hepatic impairment on the pharmacokinetics of ripretinib.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.e16031

Authors: Xiaoyan Li, Charles M Psoinos, Mark Joel Shelton, Farida Abane, Mark A. Matson, Samuel Oberstein, Rodrigo Ruiz-Soto

Institutions: Deciphera Pharmaceuticals (United States), Prism Clinical Research

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281610097

Cites:

Cited by: 1

Related to: 10